Zepp Health (ZEPP) Cost of Revenue (2016 - 2026)

Zepp Health (ZEPP) has reported Cost of Revenue for 11 consecutive years, with $32.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cost of Revenue rose 32.82% year-over-year to $32.1 million; the TTM figure through Mar 2026 stood at $167.6 million (up 50.64% YoY), while the FY2025 annual figure was $159.7 million, up 42.13% from the prior year.
• Cost of Revenue fell to $32.1 million in Q1 2026 per ZEPP's latest filing, from $50.8 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $137.1 million in Q3 2022 and bottomed at $24.2 million in Q1 2025.
• Historically, Cost of Revenue has averaged $62.1 million across 5 years, with a median of $50.8 million in 2025.
• Annual changes were most pronounced in 2024 — Cost of Revenue slumped 68.02% — and 2025, when it soared 85.84%.
• Zepp Health's Cost of Revenue stood at $123.2 million in 2022, then sank by 56.04% to $54.2 million in 2023, then tumbled by 30.57% to $37.6 million in 2024, then jumped by 34.93% to $50.8 million in 2025, then tumbled by 36.73% to $32.1 million in 2026.
• Business Quant data shows ZEPP's Cost of Revenue at $32.1 million in Q1 2026, $50.8 million in Q4 2025, and $46.9 million in Q3 2025.